- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Optimizing EoE Care in Pediatric Patients: Treatments and Shared Decision-Making
Mirna Chehade, MD, MPH, emphasizes the value of proton pump inhibitors, swallowed corticosteroids, and dietary restrictions as therapeutic options for pediatric patients with eosinophilic esophagitis (EoE), while underscoring the importance of shared decision-making to maintain adherence and achieve better outcomes.
EP: 1.Understanding EoE Pathophysiology: Age-Dependent Challenges
EP: 2.EoE Management: Timely Diagnosis and Multifaceted Treatment Goals
EP: 3.Optimizing EoE Care in Pediatric Patients: Treatments and Shared Decision-Making
EP: 4.EoE in Pediatric Patients: Managing Adverse Events and Treatment Choices
EP: 5.Overcoming Treatment Challenges in EoE
EP: 6.Future EoE Treatments and Practices
This is a video synopsis/summary of an Insights involving Mirna Chehade, MD, MPH.
Chehade explores the role of proton pump inhibitors and oral glucocorticoids in treating pediatric eosinophilic esophagitis (EoE), emphasizing their necessity for long-term management. Treatment sequencing involves shared decision-making with parents and older children, ensuring better outcomes and adherence. Nonpharmacological options, such as dietary restriction therapies, require careful consideration based on factors like age, nutritional status, and social/financial support. Acceptance of multiple endoscopies is crucial for identifying trigger foods in remission. The discussion underscores the need for an individualized approach, balancing pharmacological and nonpharmacological options through effective shared decision-making in pediatric EoE treatment.
Video synopsis is AI-generated and reviewed by AJMC® editorial staff.
